• Batch deviation leading to scrappage or rework
• Cross-contamination between product lines
• Sterility breach in fill-finish / aseptic areas
• Incorrect labelling, leaflets, or dosage statements
• Packaging failure (seal integrity, tamper-evidence, blisters)
• Temperature excursion during storage or distribution
• Equipment breakdown (tablet presses, encapsulators, autoclaves)
• Utility failure (power, compressed air, steam, purified water)

• Specialist markets for pharmaceutical manufacturing and life sciences
• Policy structures built around batch production and traceability
• Support aligning insurance submission with GMP realities
• Options for product recall, contamination and regulatory costs
• Competitive pricing with clear underwriting presentation
• Claims guidance when you need it most

• 1. Share your operations – dosage forms, sterile/non-sterile, batch volumes, markets
• 2. Confirm quality systems – GMP framework, deviations, CAPA, change control
• 3. Review exposures – recall, contamination, contracts, exports, clinical trial work
• 4. Build the programme – select limits, add-ons, endorsements, and key extensions
• 5. Bind cover – documentation, certificates, and insurer risk requirements

Underwriters price pharmaceutical risks based on clarity. The goal is to present a concise risk narrative supported by factual process detail. We’ll help you position your facility correctly so insurers don’t default to restrictive assumptions.

For example, if you operate a dedicated sterile suite with validated isolators and robust EM (environmental monitoring), that should be highlighted. If you have a mature deviation management and CAPA process, that should be evidenced. If you export, we’ll ensure territory exposure is properly declared and the policy wording matches your distribution reality.

• Blend uniformity, content uniformity and segregation controls
• Compression/encapsulation process capability and tooling integrity
• Dust explosion controls where relevant
• Cross-contamination prevention and line clearance
• Packaging and labelling error controls

Solid dose claims often originate from a deviation that wasn’t detected early enough — a scale calibration issue, an incorrect sieve, a humidity drift, or a mix-time change that shifts dissolution. Insurance needs to consider batch value, rework feasibility, release timelines and customer penalty clauses.

• Preservative efficacy and microbial control
• Viscosity, homogeneity and fill-volume controls
• Container-closure integrity and shelf-life stability
• Temperature sensitivity and storage controls
• Mixing vessel cleaning validation and residues

Liquid and topical products introduce different loss drivers such as microbial growth, preservative failure, emulsification instability, or packaging leakage. Insurers will often ask about cleaning validation, CIP/SIP capability, and the way you segregate allergens or sensitising materials.

Labelling errors can create immediate patient safety risk: incorrect strength, incorrect route of administration guidance, missing contraindications, wrong batch coding, or leaflet mismatch. Even when caught early, the cost can be high due to retrieval logistics and the urgency of patient-facing communications.

• Recall and notification costs
• Retailer / wholesaler penalties
• Regulatory scrutiny and reporting burden
• Potential bodily injury exposure

Recall insurance is often the difference between a manageable event and a destabilising financial shock. Importantly, insurers may want evidence of line clearance, barcode scanning, reconciliation, and robust packaging controls.

A stability failure may be caused by formulation incompatibility, moisture ingress, packaging selection, or storage conditions — and it often emerges late. When degradation occurs after distribution, the cost of retrieval and replacement can be substantial.

• Batch withdrawal and replacement manufacturing
• Contractual penalties for shortages
• Loss of future orders from distributors
• Investigation and testing costs

Insurance may need to include recall and reputational extensions depending on how your distribution contracts are structured. A clear story around stability management helps reduce uncertainty for insurers.

• Scrappage of batches and WIP
• Investigation, testing and root cause analysis
• Product retrieval, transport and destruction
• Equipment repair, emergency engineering and commissioning
• Overtime and expedited production runs
• Regulatory response and legal representation

If your products are temperature sensitive, cold-chain incidents can also include the cost of replacement inventory and validating that unaffected stock remains within specification — which can mean additional testing, quarantine costs and delays.

• GMP compliance framework and audit outcomes
• Deviation trends, CAPA effectiveness and change control
• Cleanroom design, segregation and contamination controls
• Traceability and batch documentation
• Supplier controls and incoming material testing
• Label control, reconciliation and line clearance
• Business continuity planning and utility resilience
• Claims history and near-miss learnings

Situation: A finished dose manufacturer identified a leaflet mismatch during distribution checks.

Impact: Rapid withdrawal was required to protect patient safety and maintain regulator confidence.

Resolution: A recall policy covered withdrawal logistics, communications support, and destruction costs, reducing the immediate cash impact and supporting a controlled response.

Situation: Refrigeration failure caused a temperature excursion affecting packaged batches awaiting shipment.

Impact: Stock was quarantined, additional testing was required, and release timelines were threatened.

Resolution: Stock deterioration / temperature failure cover responded, supporting replacement and mitigation actions while the business protected contractual commitments.

• Strong deviation management and timely CAPA closure
• Robust change control for formulation and process shifts
• Supplier qualification and incoming material controls
• Effective line clearance, reconciliation and label control
• Environmental monitoring with actionable trending
• Cleaning validation and residue control
• Batch traceability and documentation discipline
• Audit readiness and corrective action planning

• Employers’ Liability (compulsory)
• Public Liability
• Products Liability
• Property Damage (buildings/contents)
• Business Interruption (loss of gross profit)

This core structure is the starting point, but pharmaceutical operations often require additional cover sections to address recall, contamination, regulatory costs and high-value stock exposures.

• GMP expectations and audit readiness
• MHRA inspection outcomes and corrective actions
• Batch traceability and recall preparedness
• Cold chain validation and temperature monitoring controls
• Contractual compliance and customer quality agreements

Insurance doesn’t replace compliance — but the right policy structure can support you financially when compliance events trigger unexpected cost, downtime, investigations, or commercial disruption.